Voyageur Pharmaceuticals proposes converting $192,300 debt into shares at $0.155 each
Bitget2026/09/24 21:53- Voyageur Pharmaceuticals proposed converting $192,300 of debt into common shares to conserve cash.
- Settlement priced at $0.155 per share, implying issuance of 1,240,644 common shares.
- $52,300 owed to an officer to be settled with 337,419 shares.
- $140,000 owed to other creditors to be settled with 903,225 shares.
- Closing subject to regulatory sign-off, including TSX Venture Exchange final acceptance.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Raphael Zagury: Bitcoin will eventually surpass gold
Federal Reserve Bowman: AI Brings Both Opportunities and Risks to the Banking Industry, Fed Urges Strengthening of System Security Protections
Federal Reserve Vice Chair for Supervision, Bowman, warned that AI has a dual impact on the banking industry, serving both as a defensive tool and introducing new emerging risks. She urged banks to strengthen basic cybersecurity measures, including updating asset inventories, deploying multi-factor authentication, and improving vulnerability management. Bowman also stated that regulators will continue to adjust their examination approaches, implementing differentiated supervision for community banks instead of imposing blanket mandatory requirements.
FingerMotion to Buy Newbit Technology for $2.3 Million
BUZZ - Pyxis Oncology shares decline after launching equity financing
Crypto prices
More
